Effect of Hyperbaric Oxygen Therapy on Microcirculation

NCT ID: NCT03980210

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-14

Study Completion Date

2019-07-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Previous studies shoes that hyperoxia alters microcirculation.The investigators hypothesize that hyperbaric may restore microcirculation integrity. This hypothesis is supported by a recent study in rabbits, but no data exists for humans.

The study will expose fifteen healthy volunteers to a succession of different fraction of inspired oxygen and barometric pressure and assess microcirculatory and macrocirculatory changes via sidestream dark field videomicroscopy, near-infrared spectroscopy, Laser Doppler, transthoracic echocardiography and bio-impedancemetry at every step.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Microcirculation alterations and hyperoxia are known to alter ICU-patients' prognostic.

Studies have shown that hyperoxia alters healthy volunteers' microcirculation, whereas hyperbaric oxygen therapy is commonly used to facilitate cicatrization. There seems to be a paradox. A recent study in rabbits has given some evidences that hyperbaria may restore microcirculation integrity, but to date, there is no such evidences in human.

To study hyperoxia and hyperbaric induced changes in micro and macrocirculation, fifteen healthy volunteers will be exposed to successive variations of inspired oxygen fraction and barometric pressure according to a predefine sequence so that only one parameter will change from a condition to the next one :

1. FiO2 0.21 - 1 ATA
2. FiO2 1 - 1 ATA
3. FiO2 1 - 2.5 ATA
4. FiO2 0.21 - 2.5 ATA
5. FiO2 0.21 - 1 ATA

At each time, and after a 30 minutes period of exposure, measures will be made using SDF-microscopy, Laser Doppler and NIRS to assess microcirculation.

As previously described, macrocirculation can modify microcirculation due to a mechanism called hemodynamic coherence.

Hence, the investigators planned to assess macrocirculation changes at every step of the protocol using bioimpedancemetry and transthoracic echocardiography.

Each volunteer will be his own control, using the first measurements (condition 1. FiO2 0.21 - 1 ATA) as reference.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperbaric Oxygen Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hyperbaric oxygen therapy

Successive changes in fraction of inspired oxygen and barometric pressure (ATA: Atmosphere absolute)

Five successive steps:

1. FiO2 0.21 - 1 ATA
2. FiO2 1 - 1 ATA
3. FiO2 1 - 2.5 ATA
4. FiO2 0.21 - 2.5 ATA
5. FiO2 0.21 - 1 ATA

Group Type EXPERIMENTAL

Hyperbaric oxygen therapy

Intervention Type PROCEDURE

1. FiO2 0.21 - 1 ATA
2. FiO2 1 - 1 ATA
3. FiO2 1 - 2.5 ATA
4. FiO2 0.21 - 2.5 ATA
5. FiO2 0.21 - 1 ATA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hyperbaric oxygen therapy

1. FiO2 0.21 - 1 ATA
2. FiO2 1 - 1 ATA
3. FiO2 1 - 2.5 ATA
4. FiO2 0.21 - 2.5 ATA
5. FiO2 0.21 - 1 ATA

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To provide a medical certificate of fitness to dive (\< 1 year)
* Consent given for study participation
* French health insurance affiliated

Exclusion Criteria

* Temporary or definitive contra-indication to dive
* Pregnancy or \< 18 years of age
* Precedent dive \< 24 hours
* Under a legal protection measure
* Medical history of a disease known to alter microcirculation
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Lille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thibault Duburcq, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Roger Salengro, CHU

Lille, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Cousin N, Goutay J, Girardie P, Favory R, Drumez E, Mathieu D, Poissy J, Parmentier E, Duburcq T. Effects of high oxygen tension on healthy volunteer microcirculation. Diving Hyperb Med. 2022 Dec 20;52(4):260-70. doi: 10.28920/dhm52.4.260-270.

Reference Type RESULT
PMID: 36525683 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-A00053-54

Identifier Type: REGISTRY

Identifier Source: secondary_id

2018_63

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Heat Therapy and Peripheral Artery Disease
NCT06827691 NOT_YET_RECRUITING NA
Microvascular Blood Flow During Passive Heating
NCT06565221 NOT_YET_RECRUITING NA
Leg Heat Therapy in Elderly Individuals
NCT05543980 COMPLETED PHASE1